Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-08-24

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Civica, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for labetalol hydrochloride submitted by Civica, Inc. The snippet does not detail the specific changes included in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)